This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cetta, F. Articles by Barbarisi, A. Search for Related Content PubMed PubMed Citation Articles by Cetta, F. Articles by Barbarisi, A.

Thyroid Carcinoma Usually Occurs in Patients with Familial Adenomatous Polyposis in the Absence of Biallelic Inactivation of the Adenomatous Polyposis Coli Gene¹

Interuniversity Center for Research in Hepatobiliary Disease, Institute of Surgical Clinics, University of Siena, 53100 Siena; Department of Pathology, University of Chieti (M.C.C., A.C., P.B.), Chieti; and Institute of Surgical Clinics, Second University of Naples (A.B.), Naples, Italy

Address all correspondence and requests for reprints to: Francesco Cetta, M.D., Institute of Surgical Clinics, University of Siena, Nuovo Policlinico, Viale Bracci, 53100 Siena, Italy. E-mail: cetta{at}unisi.it

Abstract

Papillary thyroid carcinoma (PTC) is a rare extracolonic manifestation of familial adenomatous polyposis, determined by germline mutations of the adenomatous polyposis coli (APC) gene. The aim of this study was to assess the presence of loss of heterozygosity of APC in the thyroid tumoral tissue. Specimens from six female patients, aged 20–36, were analyzed for germline and somatic mutations of the APC gene by restriction enzyme analysis and sequence analysis. Five of the six also had analysis for ret/PTC, a chimeric gene, the activation of which is restricted to papillary TC. Because a previous study showed that germline mutations in familial adenomatous polyposis-associated thyroid carcinoma were located between codons 140 and 1513, the search for somatic mutations of the APC gene was restricted to this genomic area. Three of the six patients, belonging to the same kindred, had a germline mutation at codon 1061. The remaining three, one per kindred, had germline mutations at codons 1061, 1061, and 1309, respectively. None of the six patients had loss of heterozygosity for APC or somatic mutation in the explored genomic area (codon 545 and codons 1061–1678). Four of five had activation of ret/PTC in the thyroid tumoral tissue, as ret/PTC1 isoform.

Either APC has a tissue-specific dominant effect in the thyroid gland or the germline mutation confers a generic susceptibility to cancer development, but other factors (sex-related factors, environmental radiation, modifier genes) are also required for TC development. This usually involves ret/PTC activation, suggesting a possible cooperation between altered function of APC and gain of function of ret.

This article has been cited by other articles:

				D. C. Chung, M. M. Maher, and W. C. Faquin Case 37-2006 -- A 19-Year-Old Woman with Thyroid Cancer and Lower Gastrointestinal Bleeding N. Engl. J. Med., November 30, 2006; 355(22): 2349 - 2357. [Full Text] [PDF]

				J D McKay, D Thompson, F Lesueur, K Stankov, A Pastore, C Watfah, S Strolz, G Riccabona, R Moncayo, G Romeo, et al. Evidence for interaction between the TCO and NMTC1 loci in familial non-medullary thyroid cancer J. Med. Genet., June 1, 2004; 41(6): 407 - 412. [Abstract] [Full Text] [PDF]

				C. D. Malchoff and D. M. Malchoff The Genetics of Hereditary Nonmedullary Thyroid Carcinoma J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2455 - 2459. [Full Text] [PDF]